ECRM_1170x120_8-1-17

Probuphine (buprenorphine)

Titan teams with AllianceRx Walgreens Prime

Titan teams with AllianceRx Walgreens Prime

SOUTH SAN FRANCISCO, Calif.  — Titan Pharmaceuticals announced Thursday the execution of a specialty pharmacy distribution and services agreement with AllianceRx Walgreens Prime that will expand patient access to treatment with Probuphine (buprenorphine) implant, Titan’s unique six-month maintenance treatment for opioid use disorder (OUD) in eligible patients. Titan expects the majority of Probuphine sales in the

Drugs targeting metastatic cancers, opioid addiction now available through AllianceRx Walgreens Prime

Drugs targeting metastatic cancers, opioid addiction now available through AllianceRx Walgreens Prime

ORLANDO, Fla. — AllianceRx Walgreens Prime, a leading central specialty and home delivery pharmacy, can now offer new medicines to patients with certain rare, chronic and complex conditions. Known as limited distribution drugs, these hard-to-find medicines treat rare conditions such as advanced cancer of the stomach, community-acquired bacterial pneumonia (CABP), and opioid addiction, to name a